R. Shah

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
R B Shah, Rajal B Shah, Rajal Shah, Rajal B. Shah
Publication record
207 papers · 21,766 citations · H-index 67

PAPERS

Point/Counterpoint: Gleason Score 6/Grade Group 1 Prostate Cancer Should Renamed as "Non-cancer" to Improve Public Health-A Wrong Idea From a Pathologist's Perspective.
20231 citationsauthor #1
Abstract PR004: Exploring the role of ASCL1 in neuroendocrine prostate cancer
20231 citationsauthor #8
Should grade group 1 prostate cancer be reclassified as "non-cancer"? A pathology community perspective.
20225 citationsauthor #6
Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists
20221 citationsauthor #4
Myxoid Pseudotumor Involving the Renal Sinus
20227 citationsauthor #5
Enrichment of “Cribriform” morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer
20229 citationsauthor #1
Interobserver Reproducibility of Quantifying Gleason Pattern 4 Cancer in Prostate Biopsy: Implications for Clinical Practice
20220 citationsauthor #13
Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy
20222 citationsauthor #8
Cribriform Lesions of the Prostate Gland.
20225 citationsauthor #2
Renal Cell Carcinoma With Fibromyomatous Stroma-The Whole Story.
202229 citationsauthor #1
Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.
202216 citationsauthor #10
Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer-a Prospective Multi-level MRI-based Dose Escalation Trial.
202117 citationsauthor #14
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
2021221 citationsauthor #34
Synchronous dual malignancies: Carcinoma larynx and hepatocellular carcinoma
20210 citationsauthor #6
Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia
20211 citationsauthor #34
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia
202132 citationsauthor #32
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
2021190 citationsauthor #34
2019 Gleason grading recommendations from ISUP and GUPS: broadly concordant but with significant differences
202111 citationsauthor #2
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
202138 citationsauthor #33
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations.
202130 citationsauthor #1
Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies.
202117 citationsauthor #10
Solitary plasmacytoma of the breast
20212 citationsauthor #4
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.
202011 citationsauthor #44
Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single‐institution study of more than 27,000 cases
202013 citationsauthor #3
Carcinoma glottis with parotid metastasis
20200 citationsauthor #4
Urothelial Carcinomas With Trophoblastic Differentiation, Including Choriocarcinoma
202022 citationsauthor #4
Reporting trends, practices, and resource utilization in neuroendocrine tumors of the prostate gland: A survey of genitourinary (GU) pathologists
20200 citationsauthor #5
Pattern-Based Approach to Prostate Biopsy Interpretation
20190 citationsauthor #1
“Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity
201989 citationsauthor #1
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy
201911 citationsauthor #14
Diagnosis of Limited Cancer in Prostate Biopsy
20190 citationsauthor #1
Intraductal Carcinoma of the Prostate (IDC-P) and Atypical Intraductal Proliferation (AIP)
20190 citationsauthor #1
Biopsy Specimen Handling, Processing, and Quality Assurance Program
20190 citationsauthor #1
High-Grade Prostatic Intraepithelial Neoplasia
20190 citationsauthor #1
Needle Biopsy Sampling Techniques and Role of Multiparametric-Magnetic Resonance Imaging Modality in Prostate Cancer Diagnosis and Management
20190 citationsauthor #1
Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes
201935 citationsauthor #1
Atypical Glands Suspicious for Cancer (ATYP)
20190 citationsauthor #1
Histologic Variants of Acinar Adenocarcinoma, Ductal Adenocarcinoma, Neuroendocrine Tumors, and Other Carcinomas
20194 citationsauthor #1
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate
201929 citationsauthor #31
Molecular Biology of Prostate Cancer and Role of Genomic Testing in Diagnosis and Prognosis of Prostate Cancer
20190 citationsauthor #1
Reporting of Prostate Biopsy
20190 citationsauthor #1
Contemporary Approach to Gleason Grading of Prostate Cancer
20192 citationsauthor #1
Anatomy and Normal Histology of the Prostate Pertinent to Biopsy Interpretation
20190 citationsauthor #1
Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate
201748 citationsauthor #5
GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall
201714 citationsauthor #6
HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone.
2017158 citationsauthor #7
Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma
201756 citationsauthor #1
Reply to ‘Low‐grade intraductal carcinoma of the prostate: an idea whose time has not yet come’: evidence‐based medicine suggests that the time is now
20172 citationsauthor #1
ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia.
201610 citationsauthor #1
Recent advances in prostate cancer pathology: Gleason grading and beyond
201647 citationsauthor #1
Improvement of diagnostic agreement among pathologists in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies using a novel "Disease-Focused Diagnostic Review" quality improvement process.
201617 citationsauthor #1
Signaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent.
201514 citationsauthor #3
Utility of PTEN and ERG Immunostaining for Distinguishing High-grade PIN From Intraductal Carcinoma of the Prostate on Needle Biopsy
2015107 citationsauthor #10
Primary Anal Canal Syphilis in Men: The Clinicopathologic Spectrum of an Easily Overlooked Diagnosis.
201546 citationsauthor #2
Diagnosis of “Poorly Formed Glands” Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations
201567 citationsauthor #18
Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling.
201550 citationsauthor #1
MP86-02 PREDICTIVE VALUE OF PATHOLOGIC PARAMETERS AND ERG ONCOPROTEIN EXPRESSION IN THE STRATIFICATION OF PROSTATE CANCER RISK ASSOCIATED WITH HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (HGPIN) DIAGNOSIS IN PROSTATE NEEDLE BIOPSY
20150 citationsauthor #1
New Molecular Markers of Diagnosis and Prognosis in Prostate Cancer
20152 citationsauthor #1
Diagnosis of Gleason Pattern 5 Prostate Adenocarcinoma on Core Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists
201543 citationsauthor #1
MP79-13 HETEROGENEITY OF PTEN AND ERG BIOMARKERS EXPRESSION IN PROSTATE CANCER NEEDLE BIOPSIES WITH MORE THAN ONE CORE POSITIVE: IMPLICATIONS FOR BIOMARKERS SAMPLING STRATEGY
20140 citationsauthor #1
Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading system.
201414 citationsauthor #1
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
201448 citationsauthor #30
Noninvasive Detection of TMPRSS 2 : ERG Fusion Transcripts in the Urine of Men with Prostate Cancer 1
20147 citationsauthor #7
Clinical Applications of Novel ERG Immunohistochemistry in Prostate Cancer Diagnosis and Management
201346 citationsauthor #1
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.
2013170 citationsauthor #1
The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
201349 citationsauthor #1
Atypical Cribriform Lesions of the Prostate Gland: Emerging Concepts of Intraductal Carcinoma of the Prostate (IDC-P)
20120 citationsauthor #1
Histologic Variants of Prostate Carcinoma
20120 citationsauthor #1
Benign Mimics of Prostate Carcinoma
20121 citationsauthor #1
p63, CK7, PAX8 and INI‐1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high‐grade tumours of the renal collecting system
201266 citationsauthor #4
Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer
201278 citationsauthor #5
Prostate Needle Biopsy Sampling Techniques: Impact on Pathological Diagnosis
20123 citationsauthor #1
Spindle Cell Lesions of the Prostate Gland
20121 citationsauthor #1
Carcinoma of the Collecting Ducts of Bellini and Renal Medullary Carcinoma: Clinicopathologic Analysis of 52 Cases of Rare Aggressive Subtypes of Renal Cell Carcinoma With a Focus on Their Interrelationship
2012127 citationsauthor #3
Molecular Biology of Prostate Cancer and Emerging Diagnostic and Prognostic Biomarkers
20120 citationsauthor #1
Atypical Cribriform Lesions of the Prostate: Clinical Significance, Differential Diagnosis and Current Concept of Intraductal Carcinoma of the Prostate
201249 citationsauthor #1
Anatomy and Normal Histology of the Prostate Pertinent to Biopsy Practice
20123 citationsauthor #1
Atypical Glands Suspicious for Cancer
201219 citationsauthor #1
Treatment Effect in Benign and Malignant Prostate Tissue
20120 citationsauthor #1
Immunohistochemistry in Prostate Biopsy Evaluation
20120 citationsauthor #1
Biopsy Specimen Handling, Processing, Quality Assurance Program
20120 citationsauthor #1
Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics
201150 citationsauthor #5
Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients
201181 citationsauthor #11
Comprar Prostate Biopsy Interpretation: An Illustrated Guide | Rajal B. Shah | 9783642213687 | Springer
20112 citationsauthor #1
Lymphoepithelioma-like Carcinoma of the Urinary Bladder: Clinicopathologic, Immunohistochemical, and Molecular Features
201184 citationsauthor #4
Prostate Biopsy Interpretation: An Illustrated Guide
201117 citationsauthor #1
Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques
201153 citationsauthor #3
Interobserver Reproducibility in the Diagnosis of Invasive Micropapillary Carcinoma of the Urinary Tract Among Urologic Pathologists
2010109 citationsauthor #13
Parametric PET/MR fusion imaging in prostate cancer
20100 citationsauthor #3
1165 VARIANT HISTOLOGIC DIFFERENTIATION IN UROTHELIAL CARCINOMA IS FREQUENTLY UNDER-RECOGNIZED OR DOCUMENTED IN COMMUNITY PRACTICE
20100 citationsauthor #1
Renal Metastasis from Hurthle Cell Thyroid Carcinoma and Its Evaluation with Hybrid Imaging
201017 citationsauthor #3
ETS Gene Aberrations in Atypical Cribriform Lesions of the Prostate: Implications for the Distinction Between Intraductal Carcinoma of the Prostate and Cribriform High-grade Prostatic Intraepithelial Neoplasia
201095 citationsauthor #10
Localized amyloidosis of the upper urinary tract: a case series of three patients managed with reconstructive surgery or surveillance.
201020 citationsauthor #2
Is residual neurovascular tissue on prostatectomy specimens associated with surgeon intent at nerve-sparing and postoperative quality of life measures?
201016 citationsauthor #6
Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
2010106 citationsauthor #4
Atypical Cribriform Lesions of the Prostate: Relationship to Prostatic Carcinoma and Implication for Diagnosis in Prostate Biopsies
201088 citationsauthor #1
The Discovery of Common Recurrent Transmembrane Protease Serine 2 (TMPRSS2)-Erythroblastosis Virus E26 Transforming Sequence (ETS) Gene Fusions in Prostate Cancer: Significance and Clinical Implications
200947 citationsauthor #1
NESTED UROTHELIAL CARCINOMA: A CLINICOPATHOLOGIC AND IMMUNOHISTOCHEMICAL ANALYSIS OF 33 CASES
20090 citationsauthor #3
Renal Tubulocystic Carcinoma Is Closely Related to Papillary Renal Cell Carcinoma: Implications for Pathologic Classification
2009117 citationsauthor #4
Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?
200935 citationsauthor #4

TIMELINE

1979 1 citations

1994 34 citations

2001 1,898 citations

2002 188 citations

2003 137 citations

2004 987 citations

2005 3,161 citations

2006 3,983 citations

2007 3,977 citations

2008 3,381 citations

2009 1,079 citations

2010 451 citations

2011 287 citations

2012 347 citations

2013 265 citations

2014 69 citations

2015 329 citations

2016 74 citations

2017 278 citations

2019 170 citations

2020 46 citations

2021 559 citations

2022 74 citations

2023 2 citations

R. Shah

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT